Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1142-1148
Published online before print February 7, 2008, doi: 10.1161/HYPERTENSIONAHA.107.105205
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/4/1142    most recent
HYPERTENSIONAHA.107.105205v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ong, K. L.
Right arrow Articles by Cheung, B. M.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ong, K. L.
Right arrow Articles by Cheung, B. M.Y.
Related Collections
Right arrow Clinical Studies
Right arrow Epidemiology

(Hypertension. 2008;51:1142.)
© 2008 American Heart Association, Inc.


Go Red Original Articles

Gender Difference in Blood Pressure Control and Cardiovascular Risk Factors in Americans With Diagnosed Hypertension

Kwok Leung Ong; Annette W.K. Tso; Karen S.L. Lam; Bernard M.Y. Cheung

From the Department of Medicine (K.L.O., A.W.K.T., K.S.L.L., B.M.Y.C.), University of Hong Kong, Hong Kong; and the Department of Clinical Pharmacology (B.M.Y.C.), Division of Medical Sciences, University of Birmingham, Birmingham, UK.

Correspondence to Bernard M.Y. Cheung, Department of Clinical Pharmacology, Division of Medical Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom. E-mail b.cheung{at}bham.ac.uk

Hypertension is an important risk factor for cardiovascular disease, which is the leading cause of death in women. We, therefore, analyzed gender-specific trends in the control of blood pressure and prevalence of 5 other cardiovascular risk factors (central obesity, elevated total cholesterol, low high-density lipoprotein cholesterol, hyperglycemia, and smoking) among adults with diagnosed hypertension in the United States. We included 3475 participants aged ≥18 years with diagnosed hypertension in the National Health and Nutrition Examination Survey 1999–2004. The age-adjusted prevalence of uncontrolled blood pressure was 50.8±2.1% in men and 55.9±1.5% in women, which were not significantly different and had not changed significantly with time. Central obesity, elevated total cholesterol level, and low high-density lipoprotein cholesterol were significantly more prevalent in women than in men (79.0±1.0%, 61.3±1.6%, and 39.7±1.6% versus 63.9±1.6%, 48.1±1.8%, and 35.6±1.7%, respectively; P<0.05). The age-adjusted proportion with ≥3 of the 6 risk factors studied was higher in women than in men (52.5±1.4% versus 40.9±1.8%; P<0.001), and this proportion decreased significantly by 7.7% in women from 1999–2000 to 2003–2004 (P<0.05) but not in men. Our study shows that blood pressure control in women with diagnosed hypertension was not significantly inferior compared with men and had not changed significantly in 1999–2004. However, women had higher prevalence of other concomitant cardiovascular risk factors. Although there is room for improvement in blood pressure control, our study has highlighted the importance of addressing concomitant cardiovascular risk factors in women with hypertension.


Key Words: cardiovascular risk factors • control • gender difference • hypertension • United States




This article has been cited by other articles:


Home page
Eur Heart JHome page
F. Turnbull, M. Woodward, B. Neal, F. Barzi, T. Ninomiya, J. Chalmers, V. Perkovic, N. Li, S. MacMahon, and the Blood Pressure Lowering Treatment Trialists' C
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials
Eur. Heart J., November 1, 2008; 29(21): 2669 - 2680.
[Abstract] [Full Text] [PDF]